Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT‐MMO trial.

Saved in:
Bibliographic Details
Title: Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT‐MMO trial.
Authors: Lam, Carolyn S. P.1,2 (AUTHOR) carolyn.lam@duke-nus.edu.sg, Rodriguez, Angel3 (AUTHOR), Aminian, Ali4 (AUTHOR), Ferrannini, Ele5 (AUTHOR), Heerspink, Hiddo J. L.6,7 (AUTHOR), Jastreboff, Ania M.8 (AUTHOR), Laffin, Luke J.9 (AUTHOR), Pandey, Ambarish10 (AUTHOR), Ray, Kausik K.11 (AUTHOR), Ridker, Paul M.12 (AUTHOR), Sanyal, Arun J.13 (AUTHOR), Yki‐Jarvinen, Hannele14,15 (AUTHOR), Mason, Denise16 (AUTHOR), Strzelecki, Michelle16 (AUTHOR), Bartee, Amy K.3 (AUTHOR), Cui, Can3 (AUTHOR), Hurt, Karla3 (AUTHOR), Linetzky, Bruno3 (AUTHOR), Bunck, Mathijs C.3 (AUTHOR), Nissen, Steven E.17 (AUTHOR)
Source: Obesity (19307381). Sep2025, Vol. 33 Issue 9, p1645-1656.
Database: SPORTDiscus with Full Text
Description
ISSN:19307381
DOI:10.1002/oby.24332